Cover Image

Commentary on “Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis”

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Ahmet Kağan Özkaya, Esra Türe
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pediatric Pulmonology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis
by: Jordana E. Hoppe, et al.
Published: (2025)

Comment on Perspectives and Needs of Caregivers in Protecting Their Child With Asthma From Wildfire Smoke
by: Esra Türe, et al.
Published: (2026)

Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey
by: Birce Sunman, et al.
Published: (2025)

Molecular Methods to Detect and Quantify Fungal Communities in Cystic Fibrosis Airway Specimens
by: Matthew K. Fought, et al.
Published: (2026)

Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy Children
by: Lilah D. Melzer, et al.
Published: (2025)

Impact of Elexacaftor‐Tezacaftor‐Ivacaftor on Quality of Life in Children With Cystic Fibrosis
by: Sara Kümmerli, et al.
Published: (2026)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis
by: Senthilkumar Sankararaman, et al.
Published: (2025)

The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis
by: Aqeem Azam, et al.
Published: (2025)

Respiratory Oscillometry and Multimodal Lung Function Assessment of Elexacaftor/Tezacaftor/Ivacaftor Response in Children and Young Adults With Cystic Fibrosis
by: Christos Kogias, et al.
Published: (2026)

“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
by: Tuğba Şişmanlar Eyüboğlu, et al.
Published: (2026)

Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis
by: Rebecca S. Pettit, et al.
Published: (2025)

Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
by: Laurie P. Murray, et al.
Published: (2025)

The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
by: Leslie Huang, et al.
Published: (2025)

Objectively Monitored Sleep in School‐Age Children With Cystic Fibrosis and Their Parents
by: Andrea L. Fidler, et al.
Published: (2025)

Real‐World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2–6 With Cystic Fibrosis
by: Adi Dagan, et al.
Published: (2026)

The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
by: Rebecca J. Vitale, et al.
Published: (2026)

Home Microbiological Sampling in a Pediatric Cystic Fibrosis Population: Pandemic Implementation and Ongoing Use
by: Khizra Farhan Ahmad, et al.
Published: (2026)

Interrater Reliability of a Modified Bronchoscopy Scoring Tool in Children With Cystic Fibrosis
by: Alexandra Bosetti, et al.
Published: (2025)

Increasing Cystic Fibrosis Knowledge of Parents of Children Diagnosed With the Newborn Screening Program
by: Mine Yüksel Kalyoncu, et al.
Published: (2025)

Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
by: Jeremy P. Tervo, et al.
Published: (2025)

Risk Factors and Outcomes of Pulmonary Exacerbations in Infants and Young Children With Cystic Fibrosis
by: Aoife Corcoran, et al.
Published: (2025)

Effects of Elexacaftor‐Tezacaftor‐Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis
by: Guillaume Petit, et al.
Published: (2025)

Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
by: Elizabeth Clarke, et al.
Published: (2024)

Roadmap to Global Cystic Fibrosis Care
by: Samya Z. Nasr, et al.
Published: (2025)

Cystic Fibrosis Year in Review 2024
by: Adrienne P. Savant
Published: (2025)

Pathophysiology of Cystic Fibrosis Liver Disease
by: Vania L. Kasper, et al.
Published: (2024)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
by: Cindy L. Williams, et al.
Published: (2025)

Expanding the Impact of New Cystic Fibrosis Therapies in Low‐ and Middle‐Income Countries
by: Eitan Kerem
Published: (2024)

Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
by: Rebecca Gallardo, et al.
Published: (2026)

Development of a Simplified Arabic Questionnaire of Health‐Related Quality of Life for Children With Cystic Fibrosis
by: Heba A. Ali, et al.
Published: (2025)

Microbiological Profile of Airway in Indian Children With Cystic Fibrosis: A Multicenter Prospective Cohort Study
by: Prawin Kumar, et al.
Published: (2025)

Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
by: Charissa W. Kam, et al.
Published: (2024)

Expanding Cystic Fibrosis Registries to the Rest of the World
by: Lutz Naehrlich
Published: (2026)

Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
by: Tyler Shugg, et al.
Published: (2025)

Disparities in Access to Cystic Fibrosis Therapy Across Countries
by: Bulent Karadag
Published: (2026)

Establishment and Analysis of the First Electronic Cystic Fibrosis Registry in Jordan: Demographic and Clinical Insights
by: Muna Kilani, et al.
Published: (2025)

Transforming Care in Cystic Fibrosis: The Long‐Term Impact of Quality Improvement Projects on Clinical Outcomes
by: S. Karabulut, et al.
Published: (2026)

Effect of Camel Milk on the Spirometry Parameters of Children With Cystic Fibrosis: The First Double Blind Randomized Clinical Trial
by: Seyed Javad Sayedi, et al.
Published: (2025)

Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
by: Brittany A. Wright, et al.
Published: (2025)

Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
by: Emma M. Tillman, et al.
Published: (2025)